Kythera Biopharmaceuticals

Allergan CEO: Taking over faces with a $2.1B deal
CNBC
Thu, 06/18/15 - 09:16 am
Allergan
Kythera Biopharmaceuticals
M&A
Brent Saunders
Allergan to buy Kythera Biopharmaceuticals in $2.1 billion deal
Marketwatch
Wed, 06/17/15 - 10:06 am
Allergan
Kythera Biopharmaceuticals
M&A
Kythera CEO Sees Big Profits in Double Chins
TheStreet.com
Wed, 05/20/15 - 09:01 am
Kythera Biopharmaceuticals
double chin
Kybella
Keith Leonard
FDA approves Kybella, an injection designed to melt away fat under the chin
Yahoo/AP
Thu, 04/30/15 - 10:26 am
FDA
Kybella
Kythera Biopharmaceuticals
double chin
The Hottest Question in Pharma: Which Company Will Be Next To Sell?
WSJ Pharmalot
Tue, 03/17/15 - 10:19 am
M&A
Jazz Pharmaceuticals
Anacor
Perrigo Company
Kythera Biopharmaceuticals
Akorn
Impax Laboratories
Kythera's double chin injection rolls toward FDA approval
Fierce Biotech
Fri, 03/6/15 - 11:20 am
Kythera Biopharmaceuticals
FDA
double chin
ATX-101
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
Yahoo/Globe NewsWire
Sat, 12/13/14 - 12:25 pm
Kythera Biopharmaceuticals
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 09/14/13 - 10:50 am
Geron
Aratana
Kythera Biopharmaceuticals
KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Phase IIIb Study of ATX-101 at the 11th Anti-Aging Medicine World Congress (AMWC)
Yahoo/BusinessWire
Sat, 04/6/13 - 11:07 am
ATX-101
Kythera Biopharmaceuticals
KYTHERA Biopharmaceuticals, Inc. to Present New Data at 2013 American Academy of Dermatology (AAD) Annual Meeting Demonstrating Results for ATX-101 in the Reduction of Submental Fat (SMF) or “Double Chin”
Yahoo/BusinessWire
Sat, 03/2/13 - 04:03 pm
ATX-101
obesity
weight loss
Kythera Biopharmaceuticals